Brian G. Atwood

Insider Reports History

Entity
Individual
Location
One Sansome Street, Suite 1650, San Francisco, CA
Signature
/s/ Brian G. Atwood
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian G. Atwood:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Chief Executive Officer, Director Stock Option (Right to Buy) 1.32M Mar 25, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Chief Executive Officer, Director Common Stock 249K Feb 14, 2024 Atwood-Edminster Trust dtd 4-2-2000
Clovis Oncology, Inc. Director Stock Option (right to buy) 42.2K Jun 10, 2021 Direct
Atreca, Inc. Director Stock Option (right to buy) 12K Jun 13, 2023 Direct
CERO THERAPEUTICS HOLDINGS, INC. Chief Executive Officer, Director Series A Convertible Preferred Stock 1K Feb 14, 2024 Atwood-Edminster Trust dtd 4-2-2000

Insider Reports Filed by Brian G. Atwood

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LPAA Launch One Acquisition Corp. Jul 11, 2024 0 $0 3 Jul 11, 2024 Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Mar 25, 2024 1 $0 4 Mar 27, 2024 Chief Executive Officer, Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Feb 14, 2024 4 $1M 4/A Mar 11, 2024 Chief Executive Officer, Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Feb 14, 2024 3 $1M 4/A Feb 21, 2024 Chief Executive Officer, Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 4 $1M 4 Feb 16, 2024 Chief Executive Officer, Director
BCEL Atreca, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
BCEL Atreca, Inc. Jun 8, 2022 1 $0 4 Jun 13, 2022 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 8, 2021 1 $0 4 Oct 12, 2021 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
CLVS Clovis Oncology, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director
BCEL Atreca, Inc. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director